June 1, 2022. Chiesi Global Rare Diseases announced today that it’s joining with other pharmaceutical companies to support the Jeffrey Modell Foundation's initiative, "Jeffrey's Insights," a global genetic sequencing program. The initiative is designed to identify Primary Immunodeficiency (PI) gene defects to optimize disease management and treatment. The goal of the program is to provide genetic sequencing services for people around the world who are suspected of having PIs, which are genetic defects of the immune system that result in chronic and often life-threatening infections or autoimmunity.
“We are proud to support the JMF in efforts to empower physicians with NGS testing and raise awareness about the importance of genetic sequencing," said Giacomo Chiesi, head of Chiesi Global Rare Diseases.